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ABSTRACT
Background Women attending mammography screening units (msus) and well women’s clinics (wwcs) represent 
a motivated cohort likely to engage in interventions aimed at primary breast cancer (bca) prevention.
Methods We used a feasibility questionnaire distributed to women (40–49 or 50–74 years of age) attending msus 
and wwcs in Halifax, Nova Scotia, to examine
 ■ women’s views about bca primary prevention and sources of health care information,
 ■ prevalence of lifestyle-related bca risk factors, and
 ■ predictors of prior mammography encounters within provincial screening guidelines.
Variables examined included personal profiling, comorbidities, prior mammography uptake, lifestyle behaviours, 
socioeconomic status, health information sources, and willingness to discuss or implement lifestyle modifications, or 
endocrine therapy, or both. A logistic regression analysis examined associations with prior mammography encounters.
Results Of the 244 responses obtained during 1.5 months from women aged 40–49 years (n = 75) and 50–74 years 
(n = 169), 56% and 75% respectively sought or would prefer to receive health information from within, as opposed 
to outside, health care. Lifestyle-related bca risk factors were prevalent, and most women were willing to discuss or 
implement lifestyle modifications (93%) or endocrine therapy (67%). Of the two age groups, 49% and 93% respectively 
had previously undergone mammography within guidelines. Increasing age and marital status (single, separated, or 
divorced vs. married or partnered) were independent predictors of prior mammography encounters within guidelines 
for women 40–49 years of age; no independent predictors were observed in the older age group.
Conclusions Women attending msus and wwcs seem to largely adhere to mammography guidelines and appear 
motivated to engage in bca primary prevention strategies, including lifestyle modifications and endocrine therapy. 
Women’s views as observed in this study provide a rationale for the potential incorporation of bca risk assessment 
within the “mammogram point of care” to engage motivated women in bca primary prevention strategies.
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INTRODUCTION
Breast cancer (bca) affects 1 in 8 Canadian women during 
their lifetime1,2. The disease comprises several under-
lying subtypes that are associated with varying biologic 
behaviours3,4. Of those malignancies, approximately 
65%–75% are characterized by the expression of endocrine 
receptors (estrogen receptor, or progesterone receptor, or 
both), and are influenced by the surrounding endocrine 
milieu5. Increased risk for bca has been associated with 
a number of variables that influence that endocrine mi-
lieu: menopausal status, time from menarche until first 
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live birth, higher body mass index (bmi), use of hormone 
replacement therapy6, and a number of other lifestyle- 
related factors (for example, physical inactivity or seden-
tary lifestyle, and high alcohol intake).
The improvements in bca outcomes achieved world-
wide to date have been attributed primarily to the early 
detection of cancer through secondary cancer prevention 
(that is, breast screening) and provision of adjuvant sys-
temic therapies that reduce cancer recurrence7. Primary 
prevention can be achieved through modification of some 
combination of recognized lifestyle-related bca risk factors 
(for example, high bmi, physical inactivity or sedentary 
lifestyle, and high alcohol intake) and pharmacologic 
intervention (for example, tamoxifen chemoprevention)8. 
Women attending mammography screening units (msus) 
and well women’s clinics (wwcs) potentially represent a mo-
tivated cohort likely to engage in interventions aimed at bca 
primary prevention. In Nova Scotia, the Nova Scotia Breast 
Screening Program conducts annual screening mammog-
raphy for asymptomatic women 40–49 years of age, offered 
on a self-referral basis, and screening every 2 years for those 
50–74 years of age. The prevalence of lifestyle-related risk 
factors for bca among women attending msus and wwcs and 
the views of those women about bca primary prevention 
are currently unknown.
The objectives of the present cross-sectional study, 
conducted in women 40–49 and 50–74 years of age attend-
ing msus and wwcs, were to examine
 ■ women’s views about bca primary prevention and 
sources of health care information,
 ■ prevalence of lifestyle-related risk factors for bca, and




Women 40 to 74 years of age without a prior history of 
bca who attended a msu (Nova Scotia Breast Screening 
Program, Halifax, Nova Scotia) or a wwc (Family Focus 
Group, Halifax), or both, over a 1.5-month period in 2017 
were approached to participate in a survey questionnaire 
(supplementary Appendix A1). Respondents were stratified 
according to age groups relevant to provincial screening 
guidelines (40–49 years vs. 50–74 years). “Prior mammog-
raphy encounter within guidelines” was defined as being 
within an 18-month (women aged 40–49 years) or 30-month 
period (women aged 50–74 years) from last mammography.
The study was approved by the iwk Research Eth-
ics Board.
Statistical Analysis
Participant characteristics (including their views about bca 
primary prevention and sources of health care information) 
and personal prevalence of lifestyle-related bca risk factors 
were examined by age group. The associations between 
participant characteristics and mammography behaviour 
(that is, within vs. outside guidelines) were examined using 
chi-square tests, the Student t-test, the Wilcoxon rank-sum 
test, and univariate logistic regression, as appropriate. All 
variables significant at p < 0.1 were included in a multi-
variate logistic regression model to identify independent 
predictors of mammography behaviour. Odds ratios and 
associated 95% confidence intervals are reported. Models 
were run separately for the two age groups. All statistical 
analyses were carried out using the SAS/STAT 12.1 software 
application (version 9.4: SAS Institute, Cary, NC, U.S.A.).
RESULTS
During the planned 1.5-month period, 244 women aged 
40–49 years (n = 75) and 50–74 years (n = 169) completed the 
questionnaire (Table i). Of those responders, 56% and 75% 
respectively indicated that they sought or would prefer to 
receive health information from within as opposed to from 
outside the health care system. Overall, most were willing 
to discuss or implement lifestyle modifications (93%) or en-
docrine therapy (67%) for bca prevention. Lifestyle-related 
bca risk factors were prevalent in both age cohorts: 43.2% 
(40–49 years) and 27.0% (50–74 years) had a bmi exceeding 
30; 14.9% and 25.0% consumed 1 or more alcoholic drinks 
daily; 48.6% and 38.1% did not meet exercise guidelines; 
and 54.2% and 45.8% had high rates of inactivity or a sed-
entary lifestyle.
Prior mammography encounters within provincial 
guidelines were reported by 49% of respondents 40–49 
years of age and 93% of those 50–74 years of age. In the 
univariate analysis, a number of variables were associated 
with mammography encounters (Table ii), but only age and 
marital status remained significant in the multivariate 
model (Table iii). In women 40–49 years of age, prior mam-
mography encounters (within vs. outside guidelines) were 
positively associated with increasing age (odds ratio per 
1-year increase: 1.24; 95% confidence interval: 1.01 to 1.52), 
but inversely associated with being married or partnered 
compared with being single, separated, or divorced (odds 
ratio: 0.28; 95% confidence interval: 0.08 to 0.96). In women 
50–74 years of age, no significant predictors of mammog-
raphy behaviour were identified in the multivariate an-
alysis. Most importantly, mammography behaviour was 
not associated with women’s views about bca prevention.
DISCUSSION
Women attending msus and wwcs appear motivated to 
engage in primary bca prevention strategies, including 
lifestyle modifications and possibly endocrine therapy. The 
higher enthusiasm for engaging in lifestyle modifications 
(93%) as opposed to endocrine therapy (67%) could reflect 
a genuine preference for nonpharmacologic interventions 
or a lack of sufficient knowledge about endocrine therapy. 
In our study, lifestyle-related bca risk factors, including 
high bmi, high alcohol intake, and low physical exercise 
or high inactivity, were prevalent. Lifestyle modifications 
could help to address bca risk and improve cardiovascular 
health9,10, although uptake remains low in target popula-
tions11,12. Endocrine-based pharmacologic intervention 
is another recognized bca prevention strategy for women 
at high risk for bca. Indeed, a number of risk prediction 
models currently incorporate clinico-epidemiologic 
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TABLE I Characteristics of the study participants
Characteristica Age group
40–49 Years 50–74 Years Overall
(n) (%)b (n) (%)b (n) (%)b
Participants 75 (30.7) 169 (69.3) 244 (100)
Menopausal status1
Pre- or perimenopausal 65 (97.0) 47 (28.7) 112 (45.9)
Postmenopausal 2 (3.0) 117 (71.3) 119 (48.8)
Education2
<High school or high school 10 (13.3) 54 (33.3) 64 (26.2)
≥College or university 65 (86.7) 108 (66.7) 173 (70.9)
Marital status3
Single, separated, or divorced 22 (29.7) 43 (26.4) 65 (26.6)
Married or living with partner 52 (70.3) 120 (73.6) 172 (70.5)
Employment status4
Not employed or retired 3 (4.0) 82 (50.6) 85 (34.8)
Employed (part-time or full-time) 72 (96.0) 80 (49.4) 152 (62.3)
Household income
Missing or prefer not to answer 6 (8.0) 51 (30.2) 57 (23.4)
<$60,000 20 (26.7) 38 (22.5) 58 (23.8)
$60,000–$99,999 20 (26.7) 49 (29.0) 69 (28.3)
≥$100,000 29 (38.6) 31 (18.3) 60 (24.6)
Insurance coverage5
None 3 (4.1) 10 (6.2) 13 (5.3)
Public 1 (1.3) 40 (25.0) 41 (16.8)
Private 70 (94.6) 110 (68.8) 180 (73.8)
Body mass index6
<25 17 (23.0) 59 (36.2) 76 (31.2)
25 to <30 25 (33.8) 60 (36.8) 85 (34.8)
>30 32 (43.2) 44 (27.0) 76 (31.2)
Smoking history
None 39 (52.0) 78 (46.2) 117 (48.0)
Current or ex-smoker 36 (48.0) 91 (53.8) 127 (52.0)
Alcohol use7
Daily intake
Never or <1 63 (85.1) 123 (75.0) 186 (76.2)
≥1 11 (14.9) 41 (25.0) 52 (21.3)
Binge behaviour (monthly)8
Never or <1 58 (77.3) 129 (78.2) 187 (76.6)
≥1 17 (22.7) 36 (21.8) 53 (21.7)
Average nutrition intake
Vegetable servings9a
Higher (1 to ≥2 daily) 36 (48.0) 90 (53.3) 126 (51.6)
Lower (≤4 to 6 weekly) 39 (52.0) 79 (46.7) 118 (48.4)
Fruit servings9b
Higher (1 to ≥2 daily) 38 (50.7) 93 (55.0) 131 (53.7)
Lower (≤4 to 6 weekly) 37 (49.3) 76 (45.0) 113 (46.3)
Red meat servings10
Lower (<1 weekly) 18 (26.9) 51 (34.2) 66 (25.6)
Higher (≥1 weekly) 49 (73.1) 98 (65.8) 153 (59.3)
Meeting total MVPA guidelines11
Yes 37 (51.4) 99 (61.9) 136 (55.7)
No 35 (48.6) 61 (38.1) 96 (39.3)
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variables to assess bca risk and potentially to identify 
those who could benefit from pharmacologic interventions 
(for example, selective estrogen receptor modulators and 
aromatase inhibitors)13.
Women attending msus and wwcs seem largely to ad-
here to screening mammography. The observed association 
between mammography behaviour (within vs. outside 
TABLE I Continued
Characteristica Age group
40–49 Years 50–74 Years Overall
(n) (%)b (n) (%)b (n) (%)b
Meeting resistance exercise guidelines12
Yes 18 (24.7) 38 (23.6) 56 (23.0)
No 55 (75.3) 123 (76.4) 178 (73.0)
Average daily sedentary time13
Low 33 (45.8) 84 (54.2) 117 (48.0)
High 39 (54.2) 71 (45.8) 110 (45.1)
Prior mammography encounter14
Within screening guidelines 37 (49.3) 157 (92.9) 194 (79.5)
Outside screening guidelines 38 (50.7) 12 (7.1) 50 (20.5)
Health info source
Practice15
Within health care 34 (45.3) 103 (60.9) 170 (69.7)
Outside health care 41 (54.7) 66 (39.1) 61 (25.0)
Desire16
Within health care 58 (77.3) 125 (74.0) 129 (52.9)
Outside health care 17 (22.7) 44 (26.0) 107 (43.8)
Willingness for intervention
Lifestyle modification17
Yes 70 (93.3) 152 (93.3) 222 (91.0)
No or unknownc 5 (6.7) 11 (6.7) 16 (6.6)a
Endocrine therapy18
Yes 51 (68.0) 107 (66.5) 158 (64.7)
No or unknownd 24 (32.0) 54 (33.5) 78 (32.0)b
Hysterectomy
Yes 4 (5.3) 48 (28.4) 52 (21.3)
No 71 (94.7) 121 (71.6) 192 (78.7)
Potential tamoxifen contraindication
Yes 70 (93.3) 145 (85.8) 29 (11.9)
No 5 (6.7) 24 (14.2) 215 (88.1)
Bone mineral density testing19
Yes 8 (10.7) 94 (56.3) 102 (41.8)
No 67 (89.3) 73 (43.7) 140 (57.4)
Osteopenia or osteoporosis medications
Yes 1 (1.3) 23 (13.6) 24 (9.8)
No 74 (98.7) 146 (86.4) 220 (90.2)
a In this table, the numeric footnotes refer to definitions supplied in supplementary Appendix A2 about the relevant variables.
b The sum of the response percentages for individual variables might not always equal 100%. Participants were allowed to leave questions un-
answered, resulting in missing data. For most part, missing responses totaled to less than 5%; all are specifically noted in the supplementary material.
c “Unknown” responses totaled 78% of the “No/unknown” responses (14 of 16 responses) when study participants were asked about their will-
ingness to engage in interventions to implement lifestyle modifications.
d “Unknown” responses totaled 81% of the “No/unknown” responses (63 of 78 responses) when study participants were asked about their will-
ingness to engage in interventions to implement endocrine therapy.
MVPA = moderate-to-vigorous physical activity.
guidelines) and increasing age within the group 40–49 
years of age was not surprising given the current debate 
about mammography screening in that group compared 
with the older group (50–74 years of age). The Canadian 
Task Force on Preventive Health Care recommends that 
women 40–49 years of age who are not at increased 
risk should not attend mammography screening14. The 
WOMEN’S VIEWS ON BREAST CANCER PREVENTION, Rundle et al.
e340 Current Oncology, Vol. 27, No. 3, June 2020 © 2020 Multimed Inc.
TABLE II Univariate logistic regression models for potential predictors of mammography behaviour, within compared with outside guidelines
Variable Comparison Age groupa
40–49 Years 50–74 Years
OR 95% CI OR 95% CI
Age Per 1-year increase 1.32 1.10 to 1.60 1.04 0.94 to 1.14
Body mass index Per 1-unit increase 1.00 0.94 to 1.07 0.95 0.87 to 1.04
Menopausal status Post- vs. Pre- or perimenopausal 1.03 0.06 to 17.24 0.82 0.21 to 3.17
Education ≥College vs. ≤High school 1.55 0.40 to 5.98 1.36 0.37 to 5.05
Marital status Married or partnered vs.  
Single, separated, or divorced
0.34 0.12 to 0.98 1.95 0.52 to 7.27
Employment status Employed vs. Not employed or retired Not estimable 0.63 0.17 to 2.33
Household income $60,000–$99,999 vs. <$60,000 0.07 0.01 to 0.72 0.42 0.08 to 2.19
≥$100,000 vs. <$60,000 0.25 0.08 to 0.80 1.06 0.19 to 6.03
Insurance coverage Other insurances vs.  
None or public or pharmacare only
Not estimable 0.53 0.11 to 2.60
Smoking history Current or ex-smoker vs. Never-smoker 0.69 0.28 to 1.70 0.21 0.05 to 1.00
Alcohol
Daily intake <1 vs. ≥1 1.93 0.51 to 7.24 2.30 0.69 to 7.70
Binge behaviour (monthly) <1 vs. ≥1 1.53 0.51 to 4.57 1.21 0.31 to 4.73
Nutrition intake
Vegetable servingsb Higher vs. Lowerc 1.62 0.65 to 4.03 0.80 0.24 to 2.63
Fruit servingsb Higher vs. Lowerc 1.62 0.65 to 4.04 1.79 0.54 to 5.87
Red meat servings Lower vs. Higherd 1.30 0.44 to 3.86 4.37 1.25 to 15.31
Red meat intake Yes vs. No 2.00 0.174 to 23.26 1.95 0.22 to 17.24
Meeting MVPA guidelines Yes vs. No 2.48 0.96 to 6.41 1.17 0.36 to 3.88
Meeting resistance guidelines Yes vs. No 3.62 1.13 to 11.63 0.92 0.24 to 3.58
Daily sedentary time Low vs. High 0.88 0.35 to 2.22 1.20 0.33 to 4.31
Health info source
Practice Outside vs. Within health care 1.18 0.48 to 2.93 2.01 0.52 to 7.69
Desire Outside vs. Within health care 0.65 0.22 to 1.95 1.06 0.27 to 4.12
Willingness for intervention
Lifestyle modification Willing vs. Not willing 0.63 0.10 to 4.00 1.59 0.18 to 13.89
Endocrine therapy Willing vs. Not willing 1.58 0.59 to 4.20 2.08 0.58 to 7.52
Hysterectomy surgery Yes vs. No 1.03 0.14 to 7.69 1.21 0.31 to 4.65
Bone mineral density testing Yes vs. No 1.82 0.40 to 8.26 1.59 0.47 to 5.45
Osteopenia or osteoporosis medications Yes vs. No Not estimable 0.77 0.16 to 3.77
Potential tamoxifen contraindication Yes vs. No 0.67 0.11 to 4.24 0.46 0.12 to 1.85
a Based on 244 respondents: 75 aged 40–49 years, and 169 aged 50–74 years. Statistically significant results appear in boldface type.
b One serving of vegetables is defined as 1 cup of raw leafy vegetables, or 1/2 cup of other vegetables such as carrots or peas, excluding potatoes; 
one serving of fruit is defined as 1 medium-sized fruit or 1/2 cup chopped, cooked, or canned fruit (excluding fruit juice).
c 1–2 or more servings daily compared with 4–6 servings or fewer weekly.
d Less than 1 serving compared with 1 or more servings weekly.
OR = odds ratio; CI = confidence interval; MVPA = moderate-to-vigorous physical activity.
associations between mammography behaviour and so-
cioeconomic variables such as marital status or household 
income were interesting. Previous studies have shown that 
higher individual, parental, and life-course socioeconomic 
status is positively associated with cancer screening15–17. 
Most importantly, perhaps, women’s willingness to engage 
in primary prevention strategies was not associated with 
their prior mammography behaviour, although that lack 
of an association could reflect a selection bias involving 
highly motivated women in the clinical settings of the 
present study.
The results of our study should be examined within 
the context of a number of limitations. The study involved 
women attending 1 msu and 1 wwc in an urban setting, 
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and its results should therefore not be generalized to other 
settings without further confirmatory studies. Although 
household income was significant in the univariate an-
alysis, we did not include that variable in the multivariate 
analysis because of low statistical power and missing data. 
We did not provide ample details about endocrine therapy 
to the survey respondents; it is therefore conceivable that 
women’s views toward endocrine therapy might have been 
more favourable after more detailed discussions with their 
primary care providers. Indeed, most women indicated that 
they sought or would prefer to receive health information 
from within, as opposed to outside, the health care system. 
The study should also be considered within the context 
of the potential selection bias of the respondents (that is, 
women who completed the questionnaire relative to those 
who chose not to) given the small percentage of women 
who elected to complete the questionnaire (approximately 
4%) among all those attending the msu and the wwc during 
the study period, and our inability to capture the charac-
teristics of the nonrespondent group compared with the 
respondent group.
SUMMARY
The high prevalence of lifestyle-related bca risk factors 
observed in the study and women’s views about bca pre-
vention strategies, including lifestyle modifications or 
pharmacologic interventions, could have future practical 
implications. The inclusion of women’s views on those sub-
jects and their preferred sources of health care information 
is a specifically novel aspect of the study. An assessment 
of bca risk could be incorporated into the “mammogram 
point of care” to engage motivated women in bca primary 
prevention strategies18. Ultimately, the benefits of adopting 
bca primary prevention strategies for at-risk women could 
outweigh those of early detection (that is, screening) or 
relapse prevention (that is, adjuvant therapies).
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